Regulated NPWT

Leading the future of wound healing with advanced, safe vacuum technologies

Vcare α® has transformed the landscape of Regulated Negative Pressure Wound Therapy (RNPT), setting new standards in advanced wound care.

Vcare α® regulated negative pressure wound therapy device
The Device

Safety-first regulated negative pressure

The Vcare α® was designed to provide pre-set, regulated negative pressure to open wounds with the intent to minimize the risk of bleeding, focusing on each patient's specific clinical needs.

It is equipped with specially designed, user-friendly software and electronics for bleeding detection and alarm control, complying with IEC-60601-1-8 standards. Vcare α® is the only NPWT device in the world with a registered patent for bleeding control.

Regulatory status: Vcare α® is FDA 510(k) cleared (K121817), prescription use only. Manufactured under a valid ISO 13485:2016 quality system and registered with the Israel Ministry of Health (AMAR).

  • Removes fluids and infectious materials
  • Optimizes the wound environment and enhances perfusion
  • Maintains a moist healing atmosphere
  • Facilitates wound edge approximation
  • Promotes granulation tissue formation

Distributor or importer? Select territories are open for exclusive distribution. Become a distribution partner →

Safety by Design

Engineered around patient safety

Vcare α® was built for the realities of hospital wound care: pre-set, regulated negative pressure with continuous monitoring and a full set of audible and visual alarms, complying with IEC-60601-1-8.

RNPT is recognized as one of the most significant innovations in plastic surgery of the past two decades. Vcare α® extends it with a patented bleeding detection and control system, the only one of its kind in NPWT, adding a layer of protection for the patients who need it most.

Related Publications →

Interested in Vcare α®?

Contact our team for the full brochure, technical specifications and clinical guidance.